노성훈

교수, 이사장
    
    

소속 강남세브란스병원
진료과 위장관외과
진료명 #위암 
message user image
가장 먼저 응원릴레이에 참여해 보세요.

 

힘내라, 대한민국! 고맙습니다.
의료진! 응원릴레이 함께하세요


환자 평판 키워드

0
작성된 평판이 없습니다.

MEDICAL-INTERVIEW

로봇 수술 분야 글로벌 허브 이끈다

1969년 국내 최초로 설립된 ‘연세암센터(Cancer Cente)’는 현재 국내 최고 ‘연세암병원’으로 자리매김하고 있다. 세브란스 병원 소속 암센터에서 연세의료원 산하 독자적인 병원으로 편입하며 세계적인 의료기관으로 성장하고 있는 연세암병원 노성훈 원장을 비앤에이치코리아 박보현 대표가 만났다.



Q. B&H코리아 박보현 대표(이하 박보현)
연세암병원은 1969년 국내 최초 암센터인 연세암센터가 설립된 이후 45년 만에 명칭과 소속이 바뀌어 건립되었습니다. 연세암병원을 건립하게 된 이유는 무엇일까요?
A. 연세암병원 노성훈 원장(이하 노성훈)
고령화 사회가 되면서 한국인 사망원인 1위인 암에 대해 관심이 높아지고 있습니다. 또한, 의학이 발전하고 암 조기 진단이 늘어나면서 암 치료율은 70%를 넘어섰고, 암 환자의 생존율도 높아지는 추세입니다. 한편, 암을 경험한 암유병자는 200만 명을 넘어서고 있는데, 이는 암이 완치되었다 하더라도 또 다른 암이 발생할 가능성이 늘어나고 있다는 의미이기도 합니다. 암은 유전자 질환이기 때문에 한번 암이 발생한 사람은 재발하거나 다른 암에도 노출될 가능성이 높습니다. 암을 이기기 위해서는 치료뿐만 아니라 ‘예방-진단-치료-재활’의 토탈 케어가 필요합니다. 암 치료의 토탈 케어가 가능한 암병원 건립으로 독자적인 경영을 통해 더욱 전문적인 암 치료가 가능해졌습니다.

Q. 박보현 : 암 치료에 있어 토탈 케어가 중요한 이유는 무엇일까요?
A. 노성훈 : 암이 생기기 전의 사전예방을 1차 예방, 초기 암 상태를 빨리 발견하고 치료하는 2차 예방, 그리고 환자의 재활을 중심으로 하는 3차 예방으로 분류합니다. 그동안 대부분 환자와 의료기관은 2차 예방인 조기 진단에 많은 관심을 가져왔습니다. 하지만, 암유병자의 암 발생 가능성이 높기 때문에 예방에서 재활까지 통합적이고 체계적인 관리가 중요합니다. 유전체에 대한 정보를 많이 알수록 암 발생 고위험군에 대한 관리가 가능함으로 1차 예방이 늘어날 수 있습니다. 또한, 최근 발전한 차세대 염기서열 분석(NGS)을 통해 암의 발생이 높은 환자와 그 가족들을 발견하고, 교육과 적극적인 검진 등을 통해 조기에 암을 발견하거나 예방적 수술 등의 치료를 할 수 있습니다.

Q. 박보현 : 연세암병원이 다른 암센터와 가장 차별화되는 부분은 무엇인지 궁금합니다. 연세암병원만의 경쟁력은 무엇일까요? 앞으로 연세암병원이 나아갈 비전에 대해서도 듣고 싶습니다.
A. 노성훈 : 가장 좋은 병원은 치료를 잘하는 병원입니다. 연세암병원은 암 치료에 있어 세계적인 수준의 경쟁력을 갖추고 있습니다. 우선, 세계적으로 우수한 의료진. 장비나 시설, 그리고 선진화된 시스템이 독립적으로 갖춰져 있습니다. 아시아 최초로 ‘로보틱 IMRT’를 도입했고, 일본보다도 먼저 한국 최초 ‘다빈치 수술 로봇’을 도입하여 지금까지 2만 건 이상의 수술을 진행했습니다. 이러한 수많은 수술 경험으로 연세암병원은 이른바 세계적인 로봇 수술의 허브가 되었다고 할 수 있습니다. 1년에 수많은 해외 의사들이 연수를 다녀가고 있으며, 연세로봇심포지엄은 라이브 서저리(Live Surgery)를 진행하며 국제적인 심포지엄이 되었습니다. 방사선 치료 분야에서도 토모테라피, 라이낙 등 방사 치료기는 물론 ‘중입자치료기’를 최초로 도입하여 현재 약 25% 정도 공사가 진행되고 있고, 2021년 시험 운전, 2022년 일반 환자 대상으로 치료가 가능해질 것으로 예상합니다. 중입자 치료기는 폐암, 간암, 췌장암 등 난치암 치료에 탁월하고 현존하는 모든 방사선 치료 장비와 비교해 암세포에 대한 치사율이 가장 높은 반면, 정상조직에 대한 선량 피폭은 가장 낮은 장비입니다. 항암치료 역시 NCCN가이드라인(National Comprehensive Cancer Network, 표준 암 치료 가이드라인)에 적합한 치료는 물론, 표준을 넘어선 재발이나 특수 케이스 환자를 대응할 수 있는 신약들의 수많은 임상 케이스를 보유하고 있습니다.

Q. 박보현 : 연세암병원은 13개 암센터 외에도 다양한 특화센터를 운영하는 것으로 알고 있습니다. 자세한 설명 부탁드립니다.
A. 노성훈 : 국내 최초 암예방센터에는 암을 이미 완치한 환자에 대해서 ‘암 생존자 프로그램 (Survivalship Program)이 있습니다. 암을 경험한 사람에 대한 적극적인 관리와 2차 암 진단을 통해 조기 위험을 발견하는 것입니다. 이외에도 식이 프로그램, 운동 프로그램, 유전체검사 등을 통해 검진이나 운동 분야 등의 전문가들이 완치 이후에도 관리한다는 점이 큰 특징입니다. 환자를 위한 프로그램 이외에도 체계화된 프로그램을 통해 전문가들을 양성하고 관리하는 역할도 하고 있습니다. 암지식정보센터에서는 환자 및 가족·보호자, 그리고 암 질환에 대한 정보가 필요한 모든 내원객을 대상으로 교육과 상담을 통해 다양한 정보와 지식을 제공하고 있습니다. 여러 진료과 의료진과 환자·보호자가 한자리에 모여 암을 진단하고 최적의 맞춤 치료를 결정하는 ‘베스트팀’ 진료를 도입한 개인맞춤치료센터 등 암 예방에서부터 치료 후의 관리가 가능한 새로운 치료 패러다임을 갖추었습니다. 흉터성형레이저센터는 암 수술 후 몸에 흉터가 남아 불편하거나 미용적인 보완이 필요한 환자분들의 흉터를 없애거나 줄여줍니다.

Q. 박보현 : 마지막으로 일반인들이 평소에 암을 예방하고 싶다면 이것만은 꼭 지켜야 한다는 생활 수칙이 있을까요?
A. 노성훈 : 널리 알려진 대로 흡연과 음주, 비만하지 않도록 생활습관을 조절하고 적절한 운동을 병행하며 저염식을 섭취하는 것이 중요합니다. 하지만 가장 중요한 것은 정기적인 검진입니다. 암을 예방하고 싶다면 1년 주기로 검진을 받는 것이 좋습니다. 암이 발견되더라도 검진 주기 내라면 암이 진전되었을 가능성이 적기 때문입니다. 유전자 검사법 등도 있지만, 모든 암을 진단하기 어렵기 때문에 검진을 통한 조기진단이 가장 중요하다고 할 수 있습니다.


Interview 비앤에이치코리아 박보현 대표 Editor 박인혁
Cooperation 비앤에이치코리아

본 내용은
No.1 라이프스타일 경영매거진 월간 씨이오앤 에서도 보실 수 있습니다.

학력

1978 연세대학교 의학과 학사
1982 연세대학교 의학과 석사
2002 고려대학교 의학과 박사

경력

1983.02 - 1986.04 국군 서울지구병원 일반외과 군의관
1996.03 - 2019.02 연세대학교 의과대학 외과 부교수,교수
2008.03 - 2009.02 연세암센터 원장
2009.03 - 2013.02 연세대학교 의과대학 외과학교실 주임교수
2009.03 - 2013.02 연세의료원 세브란스병원 외과부장
2013.03 - 2019.02 연세암병원 원장
2019.03 - 현재 강남세브라스병원 특임교수
2019.06 - 현재 국입암센터 이사장

논문

Won Hyuk Choi, MD, Sungsoo Kim, MD , Jiayun Shen, MD , Jae Ho Cheong, MD , Woo Jin Hyung, MD, Yong Il Kim, MD , Seung Ho Choi, MD , Sung Hoon Noh, MD, PhD, Chan Il Park, MD
Prognostic significance of perinodal extension in gastric cancer.
J Surg Oncol. 2007 Jun 1;95(7):540-5.
Byoung Chul Cho, MD, Hei Cheul Jeung, MD, PhD , Hye Jin Choi, MD , Sun Young Rha, MD, PhD , Woo Jin Hyung, MD , Jae Ho Cheong, MD, Sung Hoon Noh, MD, PhD, Hyun Cheol Chung, MD, PhD
Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: a 15-year experience at a single institute.
J Surg Oncol. 2007 May 1;95(6):461-8.
W.J. Hyung, C. Song J.H. Cheong, S.H. Choi and S.H. Noh
Factors influencing operation time of laparoscopy-assisted distal subtotal gastrectomy: analysis of consecutive 100 initial cases.
Eur J Surg Oncol. 2007 Apr;33(3):314-9. Epub 2006 Dec 15.
Jae-Ho Cheong, Jia Yun Shen, Chang Soo Song, Woo Jin Hyung, Jian Guo Shen, Seung Ho Choi and Sung Hoon Noh
Early Postoperative Intraperitoneal Chemotherapy Following Cytoreductive Surgery in Patients with Very Advanced Gastric Cancer.
Ann Surg Oncol. 2007 Jan;14(1):61-8. Epub 2006 Oct 22.
Complications requiring reoperation after gastrectomy for gastric cancer :
1years experience in a single institute.
J Gastrointest Surg. 2009 Feb;13(2):239-45.
Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma.
J Gastroenterol Hepatol. 2009 Mar;24(3):475-9.
Role of robotic gastrectomy using da Vinci system compared with laparoscopic gastrectomy: initial experience of 20 consecutive cases.
Surg Endosc. 2009 Jun;23(6):1204-11.
The effect of spleen-preserving lymphadenectomy on surgical outcomes of locally advanced proximal gastric cancer.
J Surg Oncol. 2009 Apr 1;99(5):275-80.
A novel modification of double stapling technique in Billroth I anastomosis
J Surg Oncol. 2009 Nov 1;100(6):518-9.
Lymph node dissection around the splenic artery and hilum in advanced middle third gastric carcinoma
Eur J Surg Oncol. 2009 Jul;35(7):709-14.
Prognostic role of p-mTOR expression in cancer tissues and metastatic lymph nodes in pT2b gastric cancer
Int J Cancer. 2009 Sep 8.
Robot-assisted gastrectomy with lymph node dissection for gastric cancer: lessons learned from an initial 100 consecutive procedures
Ann Surg. 2009 Jun;249(6):927-32.
Proposal to subclassify stage IV gastric cancer into IVA, IVB, and IVM.
Arch Surg. 2009 Jan;144(1):38-45; discussion
Long-surviving patients with recurrent GIST after receiving cytoreductive surgery with imatinib therapy
Arch Surg. 2009 Jan;144(1):38-45; discussion
Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size
J Gastrointest Surg. 2009 May;13(5):881-5.
Prediction of recurrence of early gastric cancer after curative resection.Ann Surg Oncol. 2009 Jul;16(7):1896-902.
Macroscopic Borrmann type as a simple prognostic indicator in patients with advanced gastric cancer
Oncology. 2009;77(3-4):197-204
Laparoscopic completion total gastrectomy in remnant gastric cancer: technical detail and experience of two cases
Hepatogastroenterology. 2009 Jul-Aug;56(93):1249-52.
Comparison of laparoscopic truncal vagotomy with gastrojejunostomy and open surgery in peptic pyloric stenosis.
Surg Endosc. 2009 Jun;23(6):1326-30.
In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer.
Jung JJ, Jeung HC, Chung HC, Lee JO, Kim TS, Kim YT, Noh SH, Rha SY.
Genomics. 2009;93(1):52-61.
양극단 연령층 위암 환자의 질병관련 생존율 비교.
대한외과학회지 59/5 :609-620,2000
Clinicopathological charateristics of early gastric cancer in Korea
YONSEI MEDICAL JOURNAL 41/5 :607-612,2000
위암에서 핵산함량과 휴지기 세포분획의 예후인자로서의 의의
대한외과학회지 59/5 :602-608,2000
Follicular dendritic cell sarcoma presenting as a submucosal tumor of stomach
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 124/0 :1693-1696,2000
수술 전후 수혈이 위암 환자에게 미치는 영향.
대한소화기학회지 35/2 :186-195,2000
위에 발생한 인환세포암의 임상병리학적 특성 및 예후.
대한외과학회지 59/6 :771-777,2000
Recurrence following curative resection for gastric carcinoma
BRITISH JOURNAL OF SURGERY 87/0 :236-242,2000
Early post-operative intraperitoneal chemotherapy with mitomycin-C, 5-fluorouracil and cisplatin for advanced gastric cancer
ONCOLOGY 60/1 :24-30,2001
Intraoperative needle decompression: a simple alternative to nasogastric decompression.
JOURNAL OF SURGICAL ONCOLOGY 77/4 :277-279,2001
The prognosis of stage 4 gastric carcinoma patients after curative resection
현대영미소설 48/42 :1802-1805,2001
Adjuvant 5-fluorouracil plus doxorubicin in D2-3 resected gastric carcinoma: 15-year experience at a single institute.
CANCER 91/11 :2016-2025,2001
DNA dloidy patterns in advanced gastric carcinoma: is it a clinically applicable prognosticatior?
현대영미소설 48/42 :1793-1796,2001
Early gastric carcinoma with signet ring cell histology.
CANCER 94/1 :78-83,2002
Biological phenotype determination with ex vivo model in gastric cancer for matrix-metalloproteinase inhibitor treatment.
Int J Mol Oncol 10/3 :251-256,2002
prognostic significance of metastatic lymph node ratio on T3 gastric cancer
WORLD JOURNAL OF SURGERY 26/3 :323-329,2002
동소이식을 이용한 위암의 전이모델.
대한외과학회지 / :-,2002
위암 환자에서 감시 림프절 및 고립 림프절 전이에 근거한 최소 림프절 절제에 대한 재고
대한위암학회지(journalofthekoreangastriccancerassociation) 4/4 :272-276,2002
위암 조직에서 integrin α5,α6,αv,α3,β1,β4 아단위의 발현
대한소화기학회지 40/6 :355-363,2002
Adverse effects of perioperative transfusion on patients with stage III and IV gastric cancer.
ANNALS OF SURGICAL ONCOLOGY 9/1 :5-12,2002
Comparison of gastric cancer surgery with versus without nasogastric decompression.
YONSEI MEDICAL JOURNAL 43/4 :451-456,2002
Treatment of advanced gastric cancer by palliative gastrectomy, cytoreductive therapy and postoperative intraperitoneal chemotherapy.
BRITISH JOURNAL OF SURGERY 89/4 :460-466,2002
위암 환자에서 위 절제술 후 배액관 사용에 대한 무작위 전향적 연구
대한외과학회지 63/2 :123-128,2002
Altered expression of Lewis antigen on tissue and erythrocytes in gastric cancer patients.
YONSEI MEDICAL JOURNAL 43/4 :427-434,2002
위암 환자의 암조직과 혈청내 혈관내피 성장인자의 발현과 임상병리학적 소견 및 예후와의 상관관계
대한외과학회지 62/1 :43-51,2002
위세 발생한 신경내분비암
대한외과학회지 65/4 :309-315,2003
Concerted promoter hypermethylation of hMLH1, p16INK4A, and E-cadherin in gastric carcinomas with microsatellite instability.
JOURNAL OF PATHOLOGY 200/1 :23-31,2003
복강경을 이용한 양성 위종양의 치료
대한외과학회지 64/1 :33-38,2003
Infusional Fluorouracil, Etoposide, and Cisplatin(FEP) in Advanced and Relapsed Gastric Cancer
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS 26/2 :203-209,2003
진행성 하부위암에서 췌십이지장절제술
대한외과학회지 65/6 :528-533,2003
조기위암 환자의 예후인자와 위암 특이 사망률의 분석과 그 임상적 의의
대한외과학회지 65/4 :309-315,2003
위암 환자에서 종양표지자 검사의 의의
대한외과학회지 3/2 :104-111,2003
위암 환자의 생존율 분석에 근거한 새로운 병기분류법의 제안
대한외과학회지 66/1 :20-26,2004
인터넷 홈페이즈를 통한 위암 관련 질으 및 설문조사
대한위암학회지(Journal of the Korean Gastric Cancer Association) 4/4 :219-224,2004
A phase II trial of capecitabine in previously untreated patients with advanced and/or metastatic gastric cancer
ANNALS OF ONCOLOGY 15/ :1344-1347,2004
Adeno-associated virus mediated endostatin gene therapy in combination with topoisomerase inhibitor effectively controls liver tumor in mouse model
WORLD JOURNAL OF GASTROENTEROLOGY 10/8 :1191-1197,2004
Differences in genetic expression profiles between young-age and old-age gastric adenocarcinoma using cDNA microarray for endocrine disruptor study.
ONCOLOGY REPORTS 12/ :33-39,2004
Tumor localization using laparoscopic ultrasound for a small submucosal tumor
JOURNAL OF SURGICAL ONCOLOGY 86/3 :164-166,2004
Gastric adenocarcinoma after renal transplantation
HEPATO-GASTROENTEROLOGY 51/57 :895-899,2004
Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer
GYNECOLOGIC ONCOLOGY 94/ :477-482,2004
Menetrier's disease in Korea: Report of two cases and review of cases in a gastric cancer prevalent region
YONSEI MEDICAL JOURNAL 45/3 :555-560,2004
Correlation of KIT and platelet-derived growth factor receptor α mutations with gene activation and expression profiles in gastrointestinal stromal tumors
ONCOGENE 24/ :1066-1074,2005
Laparoscopic resection of a huge intraluminal gastric submucosal tumor located in the anterior wall: Eversion method
JOURNAL OF SURGICAL ONCOLOGY 89/2 :95-98,2005
Minimally invasive treatment for gastric cancer: Approaches and selection process
JOURNAL OF SURGICAL ONCOLOGY 90/3 :188-193,2005
Frequent mutations of human Mad2, but not Bub1, in gastric cancers cause defective mitotic spindle checkpoint
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 578/ :187-201,2005
Gastric cancer surgery in cirrhotic patients: Result of gastrectomy with D2 Iymph node dissection
WORLD JOURNAL OF GASTROENTEROLOGY 11/30 :4623-4627,2005
Pretreatment anemia is associated with poorer survival in patients with stage I and II gastric cancer
JOURNAL OF SURGICAL ONCOLOGY 91/ :126-130,2005
Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomography
CANCER 103/ :2383-2390,2005
Gene copy number change events at chromosome 20 and their association with recurrence in gastric cancer patients
CLINICAL CANCER RESEARCH 11/ :612-620,2005
Quantitative detection of telomerase activity by real-time TRAP assay in the body fluids of cancer patients.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 16/5 :857-863,2005
Lymph node staging of gastric cancer using 18F-FDG PET: A Comparison Study with CT
JOURNAL OF NUCLEAR MEDICINE 46/10 :1582-1588,2005
Percutaneous needle decompression during laparoscopic gastric surgery: A simple alternative to nasogastric decompression
YONSEI MEDICAL JOURNAL 46/5 :648-651,2005
Intraoperative tumor localization using laparoscopic ultrasonography in laparoscopic-assisted gastrectomy
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 19/ :1353-1357,2005
The effect of epidural sufentanil in ropivacaine on urinary retention in patients undergoing gastrectomy
BRITISH JOURNAL OF ANAESTHESIA 97/3 :414-418,2006
CT and PET in stomach cancer: Preoperative staging and monitoring of response to therapy
RADIOGRAPHICS 26/ :143-156,2006
Influence of a microscopic positive proximal margin in the treatment of gastric adenocarcinoma of the cardia
WORLD JOURNAL OF GASTROENTEROLOGY 12/ :3883-3886,2006
The N ratio predicts recurrence and poor prognosis in patients with node-positive early gastric cancer
ANNALS OF SURGICAL ONCOLOGY 13/ :377-385,2006
Time-dependent modulation of alignment and differentiation of smooth muscle cells seeded on a porous substrate undergoing cyclic mechanical strain
ARTIFICIAL ORGANS 30/4 :250-258,2006
Adverse effect of splenectomy on recurrence in total gastrectomy cancer patients with perioperative transfusion
AMERICAN JOURNAL OF SURGERY 192/3 :301-305,2006
Operative morbidity and mortality after D2 and D4 extended dissection for advanced gastric cancer: A prospective randomized trial conducted by Asian surgeons
HEPATO-GASTROENTEROLOGY 53/69 :389-394,2006
Compairison of CT and 18F-FDG PET for Detecting Peritoneal Metastasis on the Preoperative Evaluation for Gastric Carcinoma
KOREAN JOURNAL OF RADIOLOGY 7/4 :249-256,2006
Long-term Survival after Surgical Resection for Liver Metastasis from Gastric Cancer: Two Case Reports
CANCER RESEARCH AND TREATMENT 38/3 :184-188,2006
Inhibitory effect of capsaicin on interleukin-8 production by Helicobacter pylori-infected MKN-45 cells
JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY 16/7 :1078-1083,2006
Intraoperative frozen section margin evaluation in gastric cancer of the cardia surgery
HEPATO-GASTROENTEROLOGY 53/ :976-978,2006
A phase II study of infusional 5-fluorouracil and low-dose leucovorin with docetaxel for advanced gastric cancer
ONCOLOGY 70/ :63-70,2006
복강경 보조 위 아전절제술 - 연속된 202예의 경험
대한외과학회지 71/6 :413-419,2006
근치적 위절제술 후 발생한 재발성 소장폐색증의 복강경 유착박리술
대한외과학회지 71/5 :338-343,2006
Minimally invasive treatment of obscure gastrointestinal bleeding using laparoscopic ultrasonography
SURGICAL LAPAROSCOPY ENDOSCOPY & PERCUTANEOUS TECHNIQUES 17/4 :325-327,2007
A phase II study of S-1 monotherapy administered for 2 weeks of a 3-week cycle in advanced gastric cancer patients with poor performance status
BRITISH JOURNAL OF CANCER 97/ :458-463,2007
Multi-institutional phase II study of S-1 monotherapy in advanced gastric cancer with pharmacokinetic and pharmacogenomic evaluations
ONCOLOGIST 12/5 :543-554,2007
위점막하종양의 복강경 위쐐기절제술과 개복 위쐐기절제술의 비교
대한외과학회지 72/1 :27-31,2007
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer
ANNALS OF SURGICAL ONCOLOGY 14/1 :61-68,2007
The impact of total retrieved lymph nodes on staging and survival of patients with pT3 gastric cancer
CANCER 110/4 :745-751,2007
Prognostic Significance of Perinodal Extension in Gastric Cancer
JOURNAL OF SURGICAL ONCOLOGY 95/ :540-545,2007
Prognostic impact of resection margin involvement after extended (D2/D3) gastrectomy for advanced gastric cancer: A 15-year experience at a single Institute
JOURNAL OF SURGICAL ONCOLOGY 95/ :461-468,2007
A phase II trial of weekly fractionated irinotecan and cisplatin for advanced gastric cancer
CANCER CHEMOTHERAPY AND PHARMACOLOGY 59/ :313-320,2007
Molecular basis of the differences between normal and tumor tissues of gastric cancer
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE 1772/ :1033-1040,2007
Imaging-guided minimally invasive laparoscopic resection of intraluminal small-bowel tumor: Report of two cases
AMERICAN JOURNAL OF ROENTGENOLOGY 189/ :56-60,2007
Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: A 15-year follow-up study at a single korean institute
ANNALS OF SURGICAL ONCOLOGY 14/ :2730-2737,2007
Advanced gastric carcinoma with signet ring cell histology
ONCOLOGY 72/ :64-68,2007
ATP-Based chemotherapy response assay in patients with unresectable gastric cancer
ONCOLOGY 73/73 :439-440,2007
복강경 보조 위 전절제술-연속된 77예의 경험
대한위암학회지(Journal of the Korean Gastric Cancer Association) 7/4 :206-212,2007
Factors influencing operation time of laparoscopy-assisted distal subtotal gastrectomy: Analysis of consecutive 100 initial cases
EJSO 33/ :314-319,2007
수술 중 절개창 보호 방법이 수술 후 절개창 합병증에 미치는 영향
대한위암학회지(Journal of the Korean Gastric Cancer Association) 7/4 :248-253,2007
A phase II study of paclitaxel combined with infusional 5-fluorouracil and low-dose leucovorin for advanced gastric cancer
Cancer Chemotherapy And Pharmacology 61/ :315-321,2008
Phase III trial of adjuvant 5-fluorouracil and adriamycin versus 5-fluorouracil, adriamycin, and polyadenylic-polyuridylic acid (poly A : U) for locally advanced gastric cancer after curative surgery: final results of 15-year follow-up
Annals Of Oncology 19/ :520-526,2008
Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases
Annals Of Oncology 19/ :1146-1153,2008
S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer
The Korean Journal Of Internal Medicine 23/1 :37-41,2008
Laparoscopic Spleen-Preserving Splenic Hilar Lymph Node Dissection During Total Gastrectomy for Gastric Cancer
Journal Of The American College Of Surgeons 207/2 :6-11,2008
Risk factors for lymph node metastasis in undifferentiated early gastric cancer
Annals Of Surgical Oncology 15/ :764-769,2008
Clinicopathologic characteristics and prognosis for young gastric adenocarcinoma patients after curative resection
Annals Of Surgical Oncology 15/ :1464-1469,2008
Changes in treatment outcomes of gastric cancer surgery over 45 years at a single institution
Yonsei Medical Journal 49/ :409-415,2008
Randomized clinical trial of D2 and extended paraaortic lymphadenectomy in patients with gastric cancer
International Journal Of Clinical Oncology 13/ :132-137,2008
Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan clinical oncology group study JCOG 0705 and korea gastric cancer association study KGCA01
Japanese Journal Of Clinical Oncology 38/ :504-506,2008
Angiogenic factor thymidine phosphorylase increases cancer cell invasion activity in patients with gastric adenocarcinoma
Molecular Cancer Research 6/10 :1554-1566,2008
Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
Annals Of Oncology 19/6 :1135-1140,2008
위절제술 후 빈혈에 있어서 Iron Sucrose의 효과
대한위암학회지(Journal Of The Korean Gastric Cancer Association) 8/4 :262-266,2008
Solitary lymph node metastasis in gastric cancer
Journal Of Gastrointestinal Surgery 12/ :550-554,2008
다발성 조기위암의 임상적 특징과 예후
대한위암학회지(Journal Of The Korean Gastric Cancer Association) 8/4 :198-203,2008
Mobilized CD34(+) cells as a biomarker candidate for the efficacy of combined maximal tolerance dose and continuous infusional chemotherapy and G-CSF surge in gastric cancer
Cancer Letters 270/2 :269-276,2008
In vitro pharmacogenomic database and chemosensitivity predictive genes in gastric cancer
Genomics 93/ :52-61,2009
Complications Requiring Reoperation after Gastrectomy for Gastric Cancer: 17 Years Experience in a Single Institute
Journal Of Gastrointestinal Surgery 13/ :239-245,2009
Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials
CANCER CHEMOTHERAPY AND PHARMACOLOGY 63/5 :919-927,2009
G-T haplotype (2677G > T/A and 3435C > T) of ABCB1 gene polymorphisms is associated with ethnic differences to paclitaxel sensitivity in cancer cells with different gene expression pattern
Cancer Letters 277/2 :155-163,2009
The Effect of Spleen-Preserving Lymphadenectomy on Surgical Outcomes of Locally Advanced Proximal Gastric Cancer
Journal Of Surgical Oncology 99/ :275-280,2009
Effect of being overweight on postoperative morbidity and long-term surgical outcomes in proximal gastric carcinoma
Journal Of Gastroenterology And Hepatology 24/3 :475-479,2009
Copy number changes can be a predictor for hemoglobin reduction after S-1 monotherapy in gastric cancer
International Journal Of Oncology 34/3 :787-796,2009
Endoscopic resection for undifferentiated early gastric cancer
GASTROINTESTINAL ENDOSCOPY 69/4 :1-9,2009
Role of robotic gastrectomy using da Vinci system compared with laparoscopic gastrectomy: initial experience of 20 consecutive cases
Surgical Endoscopy And Other Interventional Techniques 23/0 :1204-1211,2009
Robot-Assisted Gastrectomy With Lymph Node Dissection for Gastric Cancer Lessons Learned From an Initial 100 Consecutive Procedures
ANNALS OF SURGERY 249/ :927-932,2009
Prediction of recurrence of early gastric cancer after curative resection
Annals Of Surgical Oncology 16/7 :1896-1902,2009
Comparison of laparoscopic truncal vagotomy with gastrojejunostomy and open surgery in peptic pyloric stenosis
Surgical Endoscopy And Other Interventional Techniques 23/6 :1326-1330,2009
Clinicopathological Aspects and Prognostic Value With Respect to Age: An Analysis of 3,362 Consecutive Gastric Cancer Patients
Journal Of Surgical Oncology 99/7 :395-401,2009
Laparoscopic Completion Total Gastrectomy in Remnant Gastric Cancer: Technical Detail and Experience of Two Cases
Hepato-Gastroenterology 56/93 :1249-1252,2009
Pathological characteristics of gastrointestinal stromal tumours with PDGFRA mutations.
Pathology 41/6 :544-554,2009
Prognosis of pN3 stage gastric cancer
Cancer Research And Treatment 41/2 :73-79,2009
Long-surviving patients with recurrent GIST after receiving cytoreductive surgery with imatinib therapy
Yonsei Medical Journal 50/3 :437-440,2009
Macroscopic borrmann type as a simple prognostic indicator in patients with advanced gastric cancer
Oncology 77/3-4 :197-204,2009
A novel modification of double stapling technique in billroth i anastomosis
Journal Of Surgical Oncology 100/6 :518-519,2009
Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size
Journal Of Gastrointestinal Surgery 13/5 :881-885,2009
A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status
Oncology 77/6 :349-357,2009
Docetaxel versus Paclitaxel Combined with 5-FU and Leucovorin in Advanced Gastric Cancer: Combined Analysis of Two Phase II Trials
Cancer Research And Treatment 41/4 :196-204,2009
Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients
Cancer Letters 288/1 :124-132,2010
Two Dosages of Oral Fluoropyrimidine S-1 of 35 and 40 mg/m(2) bid: Comparison of the Pharmacokinetic Profiles in Korean Patients with Advanced Gastric Cancer
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 40/1 :29-35,2010
Association of the ABCB1 3435C > T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy
Oncology Reports 23/ :271-278,2010
MicroRNA expression profile of gastrointestinal stromal tumors is distinguished by 14q loss and anatomic site
INTERNATIONAL JOURNAL OF CANCER 126/7 :1640-1650,2010
A Phase II Study of a Combined Biweekly Irinotecan and Monthly Cisplatin Treatment for Metastatic or Recurrent Gastric Cancer
American Journal of Clinical Oncology-Cancer Clinical Trials 33/1 :56-60,2010
Clinicopathological Features and Prognostic Factors of Proximal Gastric Carcinoma in a Population with High Helicobacter pylori Prevalence: A Single-Center, Large-Volume Study in Korea
Annals of Surgical Oncology 17/ :829-837,2010
Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea
WORLD JOURNAL OF GASTROENTEROLOGY 16/2 :256-263,2010
Surgical Outcome of Metachronous Hepatic Metastases Secondary to Gastric Cancer
Hepato-Gastroenterology 57/97 :29-34,2010
Assessment of open versus laparoscopy-assisted gastrectomy in lymph node-positive early gastric cancer: A retrospective cohort analysis
Journal Of Surgical Oncology 102/1 :77-81,2010
The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 136/ :517-526,2010
Outcomes of multiple salvage chemotherapy for advanced gastric cancer: implications for clinical practice and trial design
CANCER CHEMOTHERAPY AND PHARMACOLOGY 66/4 :797-805,2010
Clinical Implication of Positive Oral Contrast Computed Tomography for the Evaluation of Postoperative Leakage After Gastrectomy for Gastric Cancer
Journal Of Computer Assisted Tomography 34/4 :537-542,2010
Preoperative Imaging of Sentinel Lymph Nodes in Gastric Cancer Using CT Lymphography
YONSEI MEDICAL JOURNAL 51/3 :407-413,2010
Should Direct Mesocolon Invasion Be included in T4 for the Staging of Gastric Cancer?
Journal Of Surgical Oncology 101/3 :205-208,2010
Chemokine growth-regulated oncogene 1 as a putative biomarker for gastric cancer progression
CANCER SCIENCE 101/10 :2200-2206,2010
Identification of Novel Gastric Cancer-Associated CNVs by Integrated Analysis of Microarray
Journal Of Surgical Oncology 102/5 :454-461,2010
CT Colonography for Postoperative Surveillance After Curative Gastrectomy in Patients With Gastric Cancer
Journal Of Surgical Oncology 102/6 :593-598,2010
In Vitro Adenosine Triphosphate Based Chemotherapy Response Assay in Gastric Cancer
Journal of Gastric Cancer 10/4 :155-161,2010
Image-based Approach for Surgical Resection of Gastric Submucosal Tumors
Journal of Gastric Cancer 10/4 :188-195,2010
Efficacy and feasibility of radiofrequency ablation for liver metastases from gastric adenocarcinoma
International Journal Of Hyperthermia 26/4 :305-315,2010
Intraoperative portable abdominal radiograph for tumor localization: a simple and accurate method for laparoscopic gastrectomy
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 25/3 :958-963,2011
High microsatellite instability predicts good prognosis in intestinal-type gastric cancers
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 26/3 :585-592,2011
Gene Expression Signature-Based Prognostic Risk Score in Gastric Cancer
CLINICAL CANCER RESEARCH 17/7 :1850-1857,2011
Lymphovascular invasion is an important predictor of lymph node metastasis in endoscopically resected early gastric cancers
ONCOLOGY REPORTS 25/ :1589-1595,2011
Eupatilin Inhibits Gastric Cancer Cell Growth by Blocking STAT3-Mediated VEGF Expression
Journal of Gastric Cancer 11/1 :16-22,2011
Recent Evolution of Surgical Treatment for Gastric Cancer in Korea
Journal of Gastric Cancer 11/1 :1-6,2011
Relevance of lymph node metastasis along the superior mesenteric vein in gastric cancer
BRITISH JOURNAL OF SURGERY 98/5 :667-672,2011
A Randomized Phase 2 Study of Docetaxel and S-1 Versus Docetaxel and Cisplatin in Advanced Gastric Cancer With an Evaluation of SPARC Expression for Personalized Therapy
CANCER 117/10 :2050-2057,2011
Predictive values of 5-fluorouracil pathway genes for S-1 treatment in patients with advanced gastric cancer
ANTI-CANCER DRUGS 22/8 :801-810,2011
A Prognostic Model to Predict Clinical Outcome in Gastric Cancer Patients with Bone Metastasis
ONCOLOGY 80/1-2 :142-150,2011
Effects of nurse navigators on health outcomes of cancer patients
CANCER NURSING 34/5 :376-384,2011
Expression of Epstein-Barr Virus Gene and Clonality of Infiltrated T Lymphocytes in Epstein-Barr Virus-associated Gastric Carcinoma
IMMUNE NETWORK 11/1 :50-58,2011
Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
CANCER CHEMOTHERAPY AND PHARMACOLOGY 68/0 :991-999,2011
Robotic Gastrectomy as an Oncologically Sound Alternative to Laparoscopic Resections for the Treatment of Early-Stage Gastric Cancers
ARCHIVES OF SURGERY 146/9 :1086-1092,2011
Early gastric cancer of signet ring cell carcinoma is more amenable to endoscopic treatment than is early gastric cancer of poorly differentiated tubular adenocarcinoma in select tumor conditions
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 25/9 :3087-3093,2011
Clinical implication of FDG-PET in advanced gastric cancer with signet ring cell histology
JOURNAL OF SURGICAL ONCOLOGY 104/6 :566-570,2011
Intrinsic Subtypes of Gastric Cancer, Based on Gene Expression Pattern, Predict Survival and Respond Differently to Chemotherapy
GASTROENTEROLOGY 141/2 :476-485,2011
Minimizing hepatic trauma with a novel liver retraction method: a simple liver suspension using gauze suture
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 25/ :3939-3945,2011
Robotic surgery for gastric canser: a technical review
Journal of Robotic Surgery 5/ :241-249,2011
Advanced Detection of Recent Changing Trends in Gastric Cancer Survival: Up-to-date Comparison by Period Analysis
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 41/ :1344-1350,2011
Oral Vitamin B12 Replacement: An Effective Treatment for Vitamin B12 Deficiency After Total Gastrectomy in Gastric Cancer Patients
ANNALS OF SURGICAL ONCOLOGY 18/ :3711-3717,2011
New Surgical Approach for Gastric Bezoar: "Hybrid Access Surgery" Combined Intragastric and Single Port Surgery
Journal of Gastric Cancer 11/4 :230-233,2011
Intracorporeal Anastomosis Using Linear Stapler in Laparoscopic Distal Gastrectomy: Comparison between Gastroduodenostomy and Gastrojejunostomy
Journal of Gastric Cancer 11/4 :212-218,2011
Long-term oncologic outcomes of 714 consecutive laparoscopic gastrectomies for gastric cancer: results from the 7-year experience of a single institute
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 26/ :130-136,2012
Additive Lymph Node Dissection may be Necessary in Minute Submucosal Cancer of the Stomach after Endoscopic Resection.
ANNALS OF SURGICAL ONCOLOGY 19/ :779-785,2012
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
LANCET 379/9813 :315-321,2012
A pilot study of S-1 plus cisplatin versus 5-fluorouracil plus cisplatin for postoperative chemotherapy in histological stage IIIB-IV (M0) gastric cancer
INVESTIGATIONAL NEW DRUGS 30/ :357-363,2012
Outcome after gastrectomy in gastric cancer patients with type 2 diabetes
WORLD JOURNAL OF GASTROENTEROLOGY 18/1 :49-54,2012
Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence
JOURNAL OF SURGICAL ONCOLOGY 105/ :405-409,2012
AMPK alpha Modulation in Cancer Progression: Multilayer Integrative Analysis of the Whole Transcriptome in Asian Gastric Cancer
CANCER RESEARCH 72/10 :2512-2521,2012
Multifocality in Early Gastric Cancer Does not Increase the Risk of Lymph Node Metastasis in a Single-Center Study
ANNALS OF SURGICAL ONCOLOGY 19/4 :1251-1256,2012
Participation and Conflict in the Decision-Making Process for Endoscopic Resection or Surgical Gastrectomy for Early Gastric Cancer
JOURNAL OF SURGICAL ONCOLOGY 106/1 :101-106,2012
Current Management and Future Strategies of Gastric Cancer
YONSEI MEDICAL JOURNAL 53/2 :248-257,2012
Impact of pretreatment thrombocytosis on blood-borne metastasis and prognosis of gastric cancer
EJSO 38/7 :562-567,2012
Microsatellite instability in sporadic gastric cancer: its prognostic role and guidance for 5-FU based chemotherapy after R0 resection
INTERNATIONAL JOURNAL OF CANCER 131/2 :505-511,2012
Endoscopic and clinicopathologic characteristics of early gastric cancer with high microsatellite instability
WORLD JOURNAL OF GASTROENTEROLOGY 18/27 :3571-3577,2012
Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 27/9 :1490-1497,2012
The diagnostic role of endoscopic submucosal dissection for gastric lesions with indefinite pathology
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 47/ :1101-1107,2012
Nuclear expression of Yes-associated protein 1 correlates with poor prognosis in intestinal type gastric cancer
ANTICANCER RESEARCH 32/9 :3827-3834,2012
Patterns of regional recurrence after curative D2 resection for stage III (N3) gastric cancer: Implications for postoperative radiotherapy
RADIOTHERAPY AND ONCOLOGY 104/3 :367-373,2012
Surgical complications in gastric cancer patients preoperatively treated with chemotherapy: their risk factors and clinical relevance preoperatively treated with chemotherapy: their risk factors and clinical relevance
ANNALS OF SURGICAL ONCOLOGY 19/8 :2452-2458,2012
Safety and Efficacy of Fast-track Surgery in Laparoscopic Distal Gastrectomy for Gastric Cancer: A Randomized Clinical Trial
WORLD JOURNAL OF SURGERY 36/12 :2879-2887,2012
Major early complications following open, laparoscopic and robotic gastrectomy
BRITISH JOURNAL OF SURGERY 99/12 :1681-1687,2012
Treatment Results of Small Intestinal Gastrointestinal Stromal Tumors Less than 10 cm in Diameter: A Comparison between Laparoscopy and Open Surgery
Journal of Gastric Cancer 12/4 :243-248,2012
Successful cholecystectomy during robotic gastrectomy
MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES 21/4 :276-281,2012
Signet Ring Cell Mixed Histology May Show More Aggressive Behavior Than Other Histologies in Early Gastric Cancer
JOURNAL OF SURGICAL ONCOLOGY 107/2 :124-129,2013
Pathologic and Oncologic Outcomes in Locally Advanced Gastric Cancer with Neoadjuvant Chemotherapy or Chemoradiotherapy
YONSEI MEDICAL JOURNAL 54/4 :888-894,2013
A Pilot Study for Preoperative Concurrent Chemoradiotherapy with S-1 and Cisplatin for Locally Advanced Gastric Cancer
HEPATO-GASTROENTEROLOGY 60/122 :382-386,2013
Staging of Adenocarcinoma of the Esophagogastric Junction: Comparison of AJCC 6th and 7th Gastric and 7th Esophageal Staging Systems
ANNALS OF SURGICAL ONCOLOGY 20/8 :2713-2720,2013
Clinical implication of endoscopic gross appearance in early gastric cancer: revisited
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 27/10 :3690-3695,2013
Comparing the short-term outcomes of totally intracorporeal gastroduodenostomy with extracorporeal gastroduodenostomy after laparoscopic distal gastrectomy for gastric cancer: a single surgeon's experience and a rapid systematic review with meta-ana
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 27/9 :3153-3161,2013
Endoscopic management of anastomotic leakage after gastrectomy for gastric cancer: how efficacious is it?
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY 48/48 :111-118,2013
Prediction of metachronous multiple primary cancers following the curative resection of gastric cancer
BMC CANCER 13/394 :1-7,2013
Defining the target volume for post-operative radiotherapy after D2 dissection in gastric cancer by CT-based vessel-guided delineation
RADIOTHERAPY AND ONCOLOGY 108/1 :72-77,2013
Prognostic Value of Early Postoperative Tumor Marker Response in Gastric Cancer.
ANNALS OF SURGICAL ONCOLOGY 20/12 :3905-3911,2013
Perioperative Nutritional Status Changes in Gastrointestinal Cancer Patients
YONSEI MEDICAL JOURNAL 54/6 :1370-1376,2013
Method of Reconstruction Governs Iron Metabolism After Gastrectomy for Patients With Gastric Cancer
ANNALS OF SURGERY 258/6 :964-969,2013
Vitamin B12 Deficiency After Gastrectomy for Gastric Cancer An Analysis of Clinical Patterns and Risk Factors
ANNALS OF SURGERY 258/6 :970-975,2013
Is the 7th TNM Edition Suitable for Biological Predictor in Early Gastric Cancer?
HEPATO-GASTROENTEROLOGY 60/125 :1225-1230,2013
Improvement of type 2 diabetes mellitus after gastric cancer surgery: Short-term outcome analysis after gastrectomy
WORLD JOURNAL OF GASTROENTEROLOGY 19/48 :9410-9417,2013
Laparoscopic Gastrectomy for Advanced Gastric Cancer: Are the Long-Term Results Comparable With Conventional Open Gastrectomy? A Systematic Review and Meta-Analysis
JOURNAL OF SURGICAL ONCOLOGY 108/8 :550-556,2013
Outcomes of laparoscopic gastrectomy after endoscopic treatment for gastric cancer: a comparison with open gastrectomy.
Journal of Gastric Cancer 13/1 :51-57,2013
Robotic versus Laparoscopic versus Open Gastrectomy: A Meta-Analysis.
Journal of Gastric Cancer 13/3 :136-148,2013
Laparoscopic total gastrectomy in a gastric cancer patient with intestinal malrotation.
Journal of Gastric Cancer 13/3 :188-191,2013
Advanced gastric cancer: is chemotherapy needed after surgery?
Expert review of gastroenterology & hepatology 7/8 :673-675,2013
Totally Laparoscopic Roux-en-Y Gastrojejunostomy after Laparoscopic Distal Gastrectomy: Analysis of Initial 50 Consecutive Cases of Single Surgeon in Comparison with Totally Laparoscopic Billroth I Reconstruction
YONSEI MEDICAL JOURNAL 55/1 :162-169,2014
Is there an optimal surgery time after endoscopic resection in early gastric cancer?
ANNALS OF SURGICAL ONCOLOGY 21/1 :232-239,2014
The Assessment of the Oncological Safety Margin of Insufficient Lymph Node Dissection in pT2 (pm) Gastric Cancer
YONSEI MEDICAL JOURNAL 55/1 :61-69,2014
Long-term Statin Therapy Improves Oncological Outcome After Radical Gastrectomy for Stage II and III Gastric Cancer
ANTICANCER RESEARCH 34/1 :355-361,2014
Risk factors for double primary malignancies and their clinical implications in patients with sporadic gastric cancer
EJSO 40/3 :338-344,2014
Self-expanding metal stents or nonstent endoscopic therapy: which is better for anastomotic leaks after total gastrectomy?
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 28/3 :833-840,2014
Minimally invasive surgery for serosa-positive gastric cancer (pT4a) in patients with preoperative diagnosis of cancer without serosal invasion
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 28/3 :866-874,2014
Anatomic extent of metastatic lymph nodes: Still important for gastric cancer prognosis
ANNALS OF SURGICAL ONCOLOGY 21/3 :899-907,2014
Can we apply the same indication of endoscopic submucosal dissection for primary gastric cancer to remnant gastric cancer?
GASTRIC CANCER 17/2 :310-315,2014
Current practice of gastric cancer treatment
CHINESE MEDICAL JOURNAL 127/3 :547-553,2014
Questions in response to "improved survival after adding dissection of the superior mesenteric vein lymph node in advanced distal gastric cancer"
SURGERY 156/3 :736-737,2014
Efficacy of Intrathecal Morphine Combined with Intravenous Analgesia versus Thoracic Epidural Analgesia after Gastrectomy
YONSEI MEDICAL JOURNAL 55/4 :1106-1114,2014
Angiogenic factor thymidine phosphorylase associates with angiogenesis and lymphangiogenesis in the intestinal-type gastric cancer
PATHOLOGY 46/4 :316-324,2014
The optimal endoscopic screening interval for detecting early gastric neoplasms
GASTROINTESTINAL ENDOSCOPY 80/2 :253-259,2014
Robotic spleen-preserving total gastrectomy for gastric cancer: comparison with conventional laparoscopic procedure
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 28/9 :2606-2615,2014
Minimally invasive surgery for remnant gastric cancer: a comparison with open surgery
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 28/8 :2452-2458,2014
Long non-coding RNA HOTAIR promotes carcinogenesis and invasion of gastric adenocarcinoma
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 451/2 :171-178,2014
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
LANCET ONCOLOGY 15/12 :1389-1396,2014
Predictors of mortality in cirrhotic patients undergoing extrahepatic surgery: comparison of Child-Turcotte-Pugh and model for end-stage liver disease-based indices
ANZ JOURNAL OF SURGERY 84/11 :832-836,2014
Is Microsatellite Instability a Prognostic Marker in Gastric Cancer?: A Systematic Review With Meta-Analysis
JOURNAL OF SURGICAL ONCOLOGY 110/2 :129-135,2014
Long Term Follow-Up and Characteristics of Cancer Negative Cases after Endoscopic Resection and Gastrectomy for Early Gastric Cancer
HEPATO-GASTROENTEROLOGY 61/135 :2133-2140,2014
Comments to young surgeons concerning laparoscopic spleen-preserving D2 lymph node dissection for advanced gastric cancer on the upper body
CHINESE JOURNAL OF CANCER RESEARCH 26/3 :231-233,2014
Proper Timing of Adjuvant Chemotherapy Affects Survival in Patients with Stage 2 and 3 Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY 22/1 :224-231,2015
Impact of carcinomatosis and ascites status on long-term outcomes of palliative treatment for patients with gastric outlet obstruction caused by unresectable gastric cancer: stent placement versus palliative gastrojejunostomy.
GASTROINTESTINAL ENDOSCOPY 81/2 :321-332,2015
Usefulness of Laparoscopic Side-to-Side Duodenojejunostomy for Gastrointestinal Stromal Tumors Located at the Duodenojejunal Junction
JOURNAL OF GASTROINTESTINAL SURGERY 19/2 :313-318,2015
Minimally invasive surgery as a treatment option for gastric cancer in the elderly: comparison with open surgery for patients 80 years and older
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 29/8 :2321-2330,2015
Clinicopathological Features and Prognostic Significance of HER2 Expression in Gastric Cancer
ONCOLOGY 88/3 :147-156,2015
Relationship Between 18F-FDG Uptake on PET and Recurrence Patterns After Curative Surgical Resection in Patients with Advanced Gastric Cancer.
JOURNAL OF NUCLEAR MEDICINE 56/10 :1494-1500,2015
Usefulness of Immunohistochemistry for Microsatellite Instability Screening in Gastric Cancer
GUT AND LIVER 9/5 :629-635 ,2015
Robotic distal subtotal gastrectomy with D2 lymphadenectomy for gastric cancer patients with high body mass index: comparison with conventional laparoscopic distal subtotal gastrectomy with D2 lymphadenectomy
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 29/11 :3251-3260,2015
Growth Patterns of Signet Ring Cell Carcinoma of the Stomach for Endoscopic Resection
GUT AND LIVER 9/6 :720-726,2015
Evolution of Gastric Cancer Treatment: From the Golden Age of Surgery to an Era of Precision Medicine
YONSEI MEDICAL JOURNAL 56/5 :1177-1185,2015
The Clinicopathologic Features and Prognostic Impact of ALK Positivity in Patients with Resected Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY 22/12 :3938-3945,2015
Poorly Differentiated Carcinoma Component in Submucosal Layer Should be Considered as an Additional Criterion for Curative Endoscopic Resection of Early Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY 22/Suppl :S772-S777,2015
Association between Chemotherapy-Response Assays and Subsets of Tumor-Infiltrating Lymphocytes in Gastric Cancer: A Pilot Study
Journal of Gastric Cancer 15/4 :223-230,2015
Risk factors for complications during surgical treatment of remnant gastric cancer
GASTRIC CANCER 18/2 :390-396,2015
Short-Term Outcomes of Laparoscopic Total Gastrectomy Performed by a Single Surgeon Experienced in Open Gastrectomy: Review of Initial Experience
Journal of Gastric Cancer 15/3 :159-166,2015
Difficulty of predicting the presence of lymph node metastases in patients with clinical early stage gastric cancer: a case control study
BMC CANCER 15/943 :-,2015
The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses.
INTERNATIONAL JOURNAL OF CANCER 137/4 :819-825,2015
Do All Patients Require Prophylactic Drainage After Gastrectomy for Gastric Cancer? The Experience of a High-Volume Center.
ANNALS OF SURGICAL ONCOLOGY 22/12 :3929-3937,2015
Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer
SCIENTIFIC REPORTS 6/22172 :1-12,2016
A Lymph Node Staging System for Gastric Cancer: A Hybrid Type Based on Topographic and Numeric Systems
PLOS ONE 11/3 :e0149555.-,2016
Cumulative Metformin Use and Its Impact on Survival in Gastric Cancer Patients After Gastrectomy
ANNALS OF SURGERY 263/1 :96-102,2016
Relationships between gastrointestinal symptoms, uncertainty, and perceived recovery in patients with gastric cancer after gastrectomy
NURSING & HEALTH SCIENCES 18/1 :23-29,2016
Risk factors for tuberculosis after gastrectomy in gastric cancer
WORLD JOURNAL OF GASTROENTEROLOGY 22/8 :2585-2591,2016
Skip lymph node metastasis in gastric cancer: is it skipping or skipped?
GASTRIC CANCER 19/1 :206-215,2016
Are new criteria for mixed histology necessary for endoscopic resection in early gastric cancer?
PATHOLOGY RESEARCH AND PRACTICE 212/5 :410-414,2016
Laparoscopic Proximal Gastrectomy with Double-Tract Reconstruction by Intracorporeal Anastomosis with Linear Staplers
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 222/5 :e39-e45,2016
Investigation of Endoscopic and Pathologic Features for Safe Endoscopic Treatment of Superficial Spreading Early Gastric Cancer
MEDICINE 95/14 :e3242-,2016
Assessment of Adrenal Function and Health-Related Quality of Life in Advanced Gastric Cancer Patients Who Received First-Line Chemotherapy
ONCOLOGY 90/5 :248-254,2016
Liver-directed treatments for liver metastasis from gastric adenocarcinoma: comparison between liver resection and radiofrequency ablation
GASTRIC CANCER 19/3 :951-960,2016
Clinical Significance of the Prognostic Nutritional Index for Predicting Short- and Long-Term Surgical Outcomes After Gastrectomy A Retrospective Analysis of 7781 Gastric Cancer Patients
MEDICINE 95/18 :e3539-,2016
Is the recent WHO histological classification for gastric cancer helpful for application to endoscopic resection?
GASTRIC CANCER 19/3 :869-875,2016
The role of tumor size in surgical decision making after endoscopic resection for early gastric cancer.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 30/7 :2799-2803,2016
Molecular Dimensions of Gastric Cancer: Translational and Clinical Perspectives
Journal of Pathology and Translational Medicine 50/1 :1-9,2016
Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience.
JOURNAL OF CANCER 7/9 :1174-1180,2016
Prognostic implications of PIK3CA amplification in curatively resected liposarcoma
ONCOTARGET 7/17 :24549-24558,2016
Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with gastric neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma
ANNALS OF NUCLEAR MEDICINE 30/4 :279-286,2016
A Novel Prediction Model of Prognosis After Gastrectomy for Gastric Carcinoma Development and Validation Using Asian Databases
ANNALS OF SURGERY 264/1 :114-120,2016
Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
BMC CANCER 16/434 :1-7,2016
Comprehensive expression profiles of gastric cancer molecular subtypes by immunohistochemistry: Implications for individualized therapy
ONCOTARGET 7/28 :44608-44620,2016
When eastern surgeons meet western patients: A pilot study of gastrectomy with lymphadenectomy in caucasian patients at a Single Korean Institute
YONSEI MEDICAL JOURNAL 57/5 :1294-1297,2016
표준화된 수술 전 교육이 위암수술 후 환자의 자가간호지식, 수행 및 신체회복에 미치는 효과
Asian Oncology Nursing 16/2 :85-93,2016
Correlation analyses between pre- and post-operative adverse events in gastric cancer patients receiving preoperative treatment and gastrectomy
BMC CANCER 16/29 :1-11,2016
Prognostic significance and frequency of EGFR expression and amplification in surgically resected advanced gastric cancer
JAPANESE JOURNAL OF CLINICAL ONCOLOGY 46/6 :507-516,2016
Robotic gastrectomy for elderly gastric cancer patients: comparisons with robotic gastrectomy in younger patients and laparoscopic gastrectomy in the elderly
GASTRIC CANCER 19/4 :1,125-1,134,2016
The Implications of Endoscopic Ulcer in Early Gastric Cancer: Can We Predict Clinical Behaviors from Endoscopy?
PLOS ONE 11/10 :e0164339-,2016
Robotic D2 Lymph Node Dissection During Distal Subtotal Gastrectomy for Gastric Cancer: Toward Procedural Standardization
ANNALS OF SURGICAL ONCOLOGY 23/8 :2409-2410,2016
Clinicopathologic Features of Gastric Carcinoma With Lymphoid Stroma in Early Gastric Cancer
JOURNAL OF SURGICAL ONCOLOGY 114/6 :769-772,2016
Sex Disparity in Gastric Cancer: Female Sex is a Poor Prognostic Factor for Advanced Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY 23/13 :4,344-4,351,2016
Recursive Partition Analysis of Peritoneal and Systemic Recurrence in Patients With Gastric Cancer Who Underwent D2 Gastrectomy: Implications for Neoadjuvant Therapy Consideration
JOURNAL OF SURGICAL ONCOLOGY 114/7 :859-864,2016
Strategies to improve treatment outcome in gastric cancer: A retrospective analysis of patients from two high-volume hospitals in Korea and China.
ONCOTARGET 7/28 :44660-44675,2016
Staging for Remnant Gastric Cancer: The Metastatic Lymph Node Ratio vs. the UICC 7th Edition System
ANNALS OF SURGICAL ONCOLOGY 23/13 :4322-4331,2016
Receptor tyrosine kinase amplified gastric cancer: Clinicopathologic characteristics and proposed screening algorithm
ONCOTARGET 7/44 :72,099-72,112,2016
Epstein-Barr virus positivity, not mismatch repair-deficiency, is a favorable risk factor for lymph node metastasis in submucosa-invasive early gastric cancer
GASTRIC CANCER 19/4 :1,041-1,051,2016
Periodic Endoscopies Might Not Increase the Detection of Early Gastric Cancer in a Young Population
PLOS ONE 11/7 :e0159759-,2016
Intestinal Glycolysis Visualized by FDG PET/CT Correlates With Glucose Decrement After Gastrectomy
DIABETES 66/2 :385-391,2017
Differential Prognostic Implications of Gastric Signet Ring Cell Carcinoma: Stage Adjusted Analysis From a Single High-volume Center in Asia
ANNALS OF SURGERY 265/5 :946-953,2017
Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 224/4 :546-555,2017
Prevalence and prognostic implications of psychological distress in patients with gastric cancer
BMC CANCER 17/1 :283-,2017
Risk-Stratification Model Based on Lymph Node Metastasis After Noncurative Endoscopic Resection for Early Gastric Cancer
ANNALS OF SURGICAL ONCOLOGY 24/6 :1,643-1,649,2017
Complementary utility of targeted next-generation sequencing and immunohistochemistry panels as a screening platform to select targeted therapy for advanced gastric cancer
ONCOTARGET 8/24 :38,389-38,398,2017
Locoregional relapse after gastrectomy with D2 lymphadenectomy for gastric cancer
BRITISH JOURNAL OF SURGERY 104/7 :877-884,2017
Effects of dexmedetomidine in combination with fentanyl-based intravenous patient-controlled analgesia on pain attenuation after open gastrectomy in comparison with conventional thoracic epidural and fentanyl-based intravenous patient-controlled ana
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES 14/10 :951-960,2017
Postoperative Helicobacter pylori Infection as a Prognostic Factor for Gastric Cancer Patients after Curative Resection
GUT AND LIVER 11/5 :635-641,2017
Clinical outcome of transarterial embolization for postgastrectomy arterial bleeding
GASTRIC CANCER 20/5 :887-894,2017
Histologic purity of signet ring cell carcinoma is a favorable risk factor for lymph node metastasis in poorly cohesive, submucosa-invasive early gastric carcinoma
GASTRIC CANCER 20/4 :583-590,2017
Distinct expression profile of key molecules in crawling-type early gastric carcinoma
GASTRIC CANCER 20/4 :612-619,2017
Additive endoscopic resection may be sufficient for patients with a positive lateral margin after endoscopic resection of early gastric cancer
GASTROINTESTINAL ENDOSCOPY 86/5 :849-856,2017
Impact of splenic hilar lymph node metastasis on prognosis in patients with advanced gastric cancer
ONCOTARGET 8/48 :84,515-84,528,2017
Consideration of clinicopathologic features improves patient stratification for multimodal treatment of gastric cancer
ONCOTARGET 8/45 :79,594-79,603,2017
Improved glycemic control with proximal intestinal bypass and weight loss following gastrectomy in non-obese diabetic gastric cancer patients
ONCOTARGET 8/61 :104,605-104,614,2017
The longest diameter of tumor as a parameter of endoscopic resection in early gastric cancer: In comparison with tumor area
PLOS ONE 12/12 :e0189649-,2017
A randomized controlled trial of Roux-en-Y gastrojejunostomy vs. gastroduodenostomy with respect to the improvement of type 2 diabetes mellitus after distal gastrectomy in gastric cancer patients
PLOS ONE 12/12 :-,2017
Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?
BMC CANCER 17/1 :287-293,2017
Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis
LANCET ONCOLOGY 19/5 :629-638,2018
Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 32/1 :73-86,2018
Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
BMC CANCER 18/1 :158-165,2018
Survival of Cancer Stem-Like Cells Under Metabolic Stress via CaMK2α-mediated Upregulation of Sarco/Endoplasmic Reticulum Calcium ATPase Expression.
CLINICAL CANCER RESEARCH 24/7 :1,677-1,690,2018
Inhibition of Wntless/GPR177 suppresses gastric tumorigenesis
BMB REPORTS 51/5 :255-260,2018
Marked Loss of Muscle, Visceral Fat, or Subcutaneous Fat After Gastrectomy Predicts Poor Survival in Advanced Gastric Cancer: Single-Center Study from the CLASSIC Trial.
ANNALS OF SURGICAL ONCOLOGY 25/11 :3,222-3,230,2018
Comparison of long-term clinical outcomes between endoscopic and surgical resection for early-stage adenocarcinoma of the esophagogastric junction
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 32/8 :3,540-3,547,2018
Parameters for Predicting Surgical Outcomes for Gastric Cancer Patients: Simple Is Better Than Complex
ANNALS OF SURGICAL ONCOLOGY 25/11 :3,239-3,247,2018
Western Validation of a Novel Gastric Cancer Prognosis Prediction Model in US Gastric Cancer Patients.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS 226/3 :252-258,2018
Long-term oncologic outcomes of robotic gastrectomy for gastric cancer compared with laparoscopic gastrectomy
GASTRIC CANCER 21/2 :285-295,2018
Long-term outcomes of endoscopic submucosal dissection in comparison to surgery in undifferentiated-type intramucosal gastric cancer using propensity score analysis
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 32/4 :2,046-2,057,2018
Modification of the TNM Staging System for Stage II/III Gastric Cancer Based on a Prognostic Single Patient Classifier Algorithm
Journal of Gastric Cancer 18/2 :142-151,2018
Multidisciplinary treatment for patients with stage IV gastric cancer: the role of conversion surgery following chemotherapy
BMC CANCER 18/1 :1116-1127,2018
S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
CANCER RESEARCH AND TREATMENT 51/1 :1-11,2019
The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer.
GASTRIC CANCER 22/1 :113-122,2019
Role of probe-based confocal laser endomicroscopy-targeted biopsy in the molecular and histopathological study of gastric cancer
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 34/1 :84-91,2019
A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy.
Journal of Clinical Medicine 8/4 :E494-,2019
A therapeutic strategy for chemotherapy-resistant gastric cancer via destabilization of both β-catenin and ras
Cancers 11/4 :496-1-496-16,2019
Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
YONSEI MEDICAL JOURNAL 60/2 :132-139,2019
European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry
EJSO 6/45 :983-988,2019
Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer
RADIOTHERAPY AND ONCOLOGY 140/ :143-149,2019
Similar hematologic and nutritional outcomes after proximal gastrectomy with double-tract reconstruction in comparison to total gastrectomy for early upper gastric cancer
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES 33/6 :1,757-1,768,2019
Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
CANCER RESEARCH AND TREATMENT 51/2 :819-831,2019
Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.
ONCOLOGY 96/2 :59-69,2019
The incidence and risk factors for surgical site infection in older adults after gastric cancer surgery A STROBE-compliant retrospective study
MEDICINE 98/32 :16,739-,2019
A Lesion-Based Convolutional Neural Network Improves Endoscopic Detection and Depth Prediction of Early Gastric Cancer.
Journal of Clinical Medicine 8/9 :E1310.-,2019
Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response
ONCOLOGIST 24/9 :e835-e844,2019
Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer Post Hoc Analysis of the CLASSIC Randomized Controlled study
ANNALS OF SURGERY 270/2 :309-316,2019
Prognostic impact of extended lymph node dissection versus limited lymph node dissection on pn0 proximal advanced gastric cancer: A propensity score matching analysis
Journal of Gastric Cancer 19/2 :212-224,2019
Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database.
JOURNAL OF SURGICAL ONCOLOGY 120/4 :676-684,2019

저서

1) 일반인을 위한 책 "위가 없어도 살 수 있나요" 발간 (2003)
2) 위암(김진복저) 제20장 원격전이가 동반된 위암의 치료 (1999)
3) 사비스톤 외과학 (정담출판사) 제43장 위 (2003)
4) 위질환의 요점과 맹점 ?번역- (2006)
5) 위암 완치 설명서 (헬스조선)- (2009)

보도자료

“초기 위암 95%이상 완치 3·4기 말기 암환자라도 버티고 견디면 기회 오죠” [나의 삶 나의 길]
http://www.segye.com/newsView/20190829516823?OutUrl=naver

입원전담 전문의 활성화로 ‘외과의사 절벽’ 넘는다
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=103&oid=032&aid=0002951910

胃 기능 살리는 축소 수술·맞춤형 항암제… 위암 치료 새 표준 만든다
https://news.naver.com/main/read.nhn?mode=LSD&mid=sec&sid1=103&oid=346&aid=0000026927

포스팅

포스팅 내용이 없습니다.

영상자료

영상자료 내용이 없습니다.

발표자료

발표자료 내용이 없습니다.